Metabolon Awarded US Patent for Determining Metabolic Age of an Individual

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announced today the grant of US Patent 7,781,160 entitled “Biomarkers Related to Metabolic Age and Methods Using the Same”. The USPTO awarded the patent to Metabolon on August 24, 2010. This is the 12th patent issued to Metabolon.

Back to news